These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 15035891)
1. Integrative tumor board: recurrent breast cancer or new primary? Radiation oncology. Hirsch A Integr Cancer Ther; 2003 Sep; 2(3):272-6. PubMed ID: 15035891 [No Abstract] [Full Text] [Related]
2. Integrative tumor board: recurrent breast cancer or new primary? Case Presentation. Schmaltz J Integr Cancer Ther; 2003 Sep; 2(3):268-70. PubMed ID: 15035889 [No Abstract] [Full Text] [Related]
3. Integrative tumor board: recurrent breast cancer or new primary? Medical oncology. Boyd DB Integr Cancer Ther; 2003 Sep; 2(3):270-2. PubMed ID: 15035890 [No Abstract] [Full Text] [Related]
4. Integrative tumor board: recurrent breast cancer or new primary? Naturopathic medicine. Fulop JA Integr Cancer Ther; 2003 Sep; 2(3):276-83. PubMed ID: 15035892 [No Abstract] [Full Text] [Related]
5. Integrative tumor board: recurrent breast cancer or new primary? UCSF Osher Center for Integrative Medicine and UCSF Carol Franc Buck Breast Care Center. Jacobs BP; Burns B; Marya R; Chapman J; Stone B; Hwang S; Goldman M; Barrows K; Hamolsky D; Sampel K Integr Cancer Ther; 2003 Sep; 2(3):289-300. PubMed ID: 15035894 [No Abstract] [Full Text] [Related]
6. Integrative tumor board: recurrent breast cancer or new primary? Mind-body-spirit medicine. Mehl-Madrona L Integr Cancer Ther; 2003 Sep; 2(3):283-9. PubMed ID: 15035893 [No Abstract] [Full Text] [Related]
7. Integrative tumor board: recurrent breast cancer or new primary? Integrative physician's perspective. Block KI Integr Cancer Ther; 2003 Sep; 2(3):301-5. PubMed ID: 15035895 [No Abstract] [Full Text] [Related]
8. [Tumor recurrence in the salvaged breast; a second chance?]. Roukema JA; Dolman A; Maat B Ned Tijdschr Geneeskd; 1989 Dec; 133(52):2593-5. PubMed ID: 2558321 [No Abstract] [Full Text] [Related]
10. Follow-up care of patients with breast cancer. Tolaney SM; Winer EP Breast; 2007 Dec; 16 Suppl 2():S45-50. PubMed ID: 17697780 [TBL] [Abstract][Full Text] [Related]
11. [Possibilities of the cytological method in the determination of therapeutic pathomorphosis of breast cancer]. Sidorova NA; Volchenko NN; Saribekian EK Sov Med; 1991; (11):15-8. PubMed ID: 1662831 [TBL] [Abstract][Full Text] [Related]
12. Some clarity in the management of DCIS in breast cancer screening. Wald NJ J Med Screen; 2011; 18(3):112. PubMed ID: 22045817 [No Abstract] [Full Text] [Related]
13. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast. Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803 [TBL] [Abstract][Full Text] [Related]
14. Ductal carcinoma in situ (DCIS). A highly treatable breast cancer. Mayo Clin Womens Healthsource; 2009 Oct; 13(10):1-2. PubMed ID: 19727033 [No Abstract] [Full Text] [Related]
15. Re: Trends in the treatment of ductal carcinoma in situ of the breast. Zorbas H; Luxford K; Evans A; Villanueva EV J Natl Cancer Inst; 2004 Aug; 96(16):1258; author reply 1259-60. PubMed ID: 15316063 [No Abstract] [Full Text] [Related]
16. Ductal carcinoma in situ of the breast: our experience. Ruggiero R; Procaccini E; Sanguinetti A; Cremone C; Gili S; Docimo G; Docimo L; Sparavigna L; Gubitosi A; Parmeggiani D; Avenia N G Chir; 2009 Mar; 30(3):121-4. PubMed ID: 19351465 [TBL] [Abstract][Full Text] [Related]
17. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer. Chadha M; Feldman S; Boolbol S; Wang L; Harrison LB Brachytherapy; 2008; 7(1):22-8. PubMed ID: 18299110 [TBL] [Abstract][Full Text] [Related]
18. Postexcisional recurrence of carcinoma of the breast. Zavotsky J; Gardner B J Am Coll Surg; 1996 Jan; 182(1):71-7. PubMed ID: 8542095 [No Abstract] [Full Text] [Related]
19. Can some DCIS patients avoid adjuvant therapy? Still unknown. Schmidt C J Natl Cancer Inst; 2011 Apr; 103(7):530-1. PubMed ID: 21436062 [No Abstract] [Full Text] [Related]